Literature DB >> 20865241

The search for undiagnosed MODY patients: what is the next step?

M T Malecki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20865241     DOI： 10.1007/s00125-010-1908-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  28 in total

Review 1.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

Authors:  S S Fajans; G I Bell; K S Polonsky
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

Review 2.  The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes.

Authors:  Katharine R Owen; Jan Skupien; Maciej T Malecki
Journal:  Diabetes Res Clin Pract       Date:  2009-12-18       Impact factor: 5.602

Review 3.  Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.

Authors:  A T Hattersley
Journal:  Diabet Med       Date:  1998-01       Impact factor: 4.359

4.  Molecular genetics goes to the diabetes clinic.

Authors:  Andrew T Hattersley
Journal:  Clin Med (Lond)       Date:  2005 Sep-Oct       Impact factor: 2.659

5.  Genetic cause of hyperglycaemia and response to treatment in diabetes.

Authors:  Ewan R Pearson; Bryan J Starkey; Roy J Powell; Fiona M Gribble; Penny M Clark; Andrew T Hattersley
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

6.  An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.

Authors:  C Cervin; O Axler; J Holmkvist; P Almgren; E Rantala; T Tuomi; L Groop; B Dahlbäck; E Karlsson
Journal:  J Intern Med       Date:  2009-06-22       Impact factor: 8.989

7.  Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).

Authors:  S A Eide; H Raeder; S Johansson; K Midthjell; O Søvik; P R Njølstad; A Molven
Journal:  Diabet Med       Date:  2008-07       Impact factor: 4.359

8.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

9.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

10.  Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes.

Authors:  Mark I McCarthy; Andrew T Hattersley
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461
View more
  4 in total

1.  All classifications not built on pathogenesis become inadequate sooner or later.

Authors:  D Iafusco; A Galderisi; F Lombardo; A Scaramuzza; E Tartaglia; A Cocca; R Giugliano; B Giugliano; T Sena; A Napoli; P Mastrantonio; F Stoppoloni; F Prisco
Journal:  Diabetologia       Date:  2011-03-13       Impact factor: 10.122

2.  Developing a framework for implementation of genetic services: learning from examples of testing for monogenic forms of common diseases.

Authors:  Tessel Rigter; Lidewij Henneman; Jacqueline E W Broerse; Maggie Shepherd; Ignacio Blanco; Ulf Kristoffersson; Martina C Cornel
Journal:  J Community Genet       Date:  2014-06-04

Review 3.  Monogenic models: what have the single gene disorders taught us?

Authors:  Tomasz Klupa; Jan Skupien; Maciej T Malecki
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

Review 4.  Monogenic Diabetes Modeling: In Vitro Pancreatic Differentiation From Human Pluripotent Stem Cells Gains Momentum.

Authors:  Juan Ignacio Burgos; Ludovic Vallier; Santiago A Rodríguez-Seguí
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.